Alternatives for Reducing Tics in TS: A Study of TEV-50717 (Deutetrabenazine) for the Treatment of Tourette Syndrome in Children and Adolescents.

Condition:   TOURETTE SYNDROME Interventions:   Drug: TEV-50717;   Drug: Placebo Sponsor:   Teva Branded Pharmaceutical Products, R&D  Inc. Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials